StockTipsArenaBeta

BUY Sun Pharmaceutical Industries Ltd. — Ajit Mishra, Religare

BUYSun Pharmaceutical Industries Ltd.

byAjit Mishra, ReligareHorizon: NA (inferred Swing (≤2wk))9 Jul 2026via Business Standard Markets

Entry₹1,888.2Stated
Target₹2,025
Total upside +7.24% (call closed)
Stop loss₹1,830-3.08% risk
At expiry₹1,943.922 Jul 2026, 3:30 pm
Expired+2.95%
Follow Ajit Mishra for new calls(26% target hit, 87 closed calls)Get alertsWatch SUNPHARMA for new buy/sell callsGet alertsSee 126 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 22 Jul 2026
2 supporting0 opposing
Supports the BUY call (2)

Sun Pharmaceutical Industries Limited has received approval to manufacture and market a generic version of semaglutide in South Africa, expanding its product portfolio and market access.

NSE · Press Release·15 Jul · 1w ago

(opens in new tab)

2 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·15 Jul · 1w ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.